Houston Chronicle interview with Immatics US CEO Harpreet Singh

| USA, News

"We are not looking just for a short extension of life by a few weeks or a few months. We're looking for something that will last (...)". 

Harpreet Singh, CEO and President of Immatics US, got interviewed by the Houston Chronicle. Read the full article published on Feb 18, 2018, at: http://bit.ly/2EC9ZVc.

Press Contact

Dr Nikola Wiegeler

Press contact,
Immatics Biotechnologies GmbH

+49 7071 5397-0

Go back